It is currently uncertain as to whether methylation or gene expression patterns are altered in DNMT3Amutated AML. In vitro, missense mutations at R882 result in increased proliferation, and mutated DNMT3A has been found to have reduced methylation activity [37]. The gene discussed is DNMT3A; the disease is acute myeloid leukemia.